相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2
Li Lai et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Anti-cancer Effect of Spinach Glycoglycerolipids as Angiogenesis Inhibitors Based on the Selective Inhibition of DNA Polymerase Activity
N. Maeda et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
Status of Bi- and Multi-Nuclear Platinum Anticancer Drug Development
Jinchao Zhang et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Plumbagin activates ERK1/2 and Akt via superoxide, Src and PI3-kinase in 3T3-L1 Cells
Su-Jung Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Plumbagin promotes the generation of astrocytes from rat spinal cord neural progenitors via activation of the transcription factor Stat3
Yongquan Luo et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia
Tae Gen Son et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo
Kai-Hong Xu et al.
LEUKEMIA RESEARCH (2010)
Functional Restoration of BRCA2 Protein by Secondary BRCA2 Mutations in BRCA2-Mutated Ovarian Carcinoma
Wataru Sakai et al.
CANCER RESEARCH (2009)
Regulation of HSulf-1 Expression by Variant Hepatic Nuclear Factor 1 in Ovarian Cancer
Peng Liu et al.
CANCER RESEARCH (2009)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Von Hippel-Lindau Gene Product Modulates TIS11B Expression in Renal Cell Carcinoma IMPACT ON VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION IN HYPOXIA
Sutapa Sinha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Inhibition of Lysine Acetyltransferase KAT3B/p300 Activity by a Naturally Occurring Hydroxynaphthoquinone, Plumbagin
Kodihalli C. Ravindra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells
Clay C. C. Wang et al.
CANCER LETTERS (2008)
Plumbagin, a Medicinal Plant-Derived Naphthoquinone, Is a Novel Inhibitor of the Growth and Invasion of Hormone-Refractory Prostate Cancer
Moammir H. Aziz et al.
CANCER RESEARCH (2008)
Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer
Arezoo Astanehe et al.
JOURNAL OF CELL SCIENCE (2008)
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Wataru Sakai et al.
NATURE (2008)
Plumbagin-induced Apoptosis in Human Prostate Cancer Cells is Associated with Modulation of Cellular Redox Status and Generation of Reactive Oxygen Species
Anna A. Powolny et al.
PHARMACEUTICAL RESEARCH (2008)
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Flavia Pichiorri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents
K. A. Thasni et al.
ANNALS OF ONCOLOGY (2008)
Radiosensitizing effects of plumbagin in cervical cancer cells is through modulation of apoptotic pathway
Sreekala Nair et al.
MOLECULAR CARCINOGENESIS (2008)
Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-κB activation and NF-κB-regulated gene products through modulation of p65 and IκBα kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents
Santosh K. Sandur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
R Satchi-Fainaro et al.
NATURE MEDICINE (2004)
Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation
JH Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells
P Srinivas et al.
MOLECULAR CARCINOGENESIS (2004)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells
G Srinivas et al.
MOLECULAR CARCINOGENESIS (2004)
Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation
SN Powell et al.
ONCOGENE (2003)
Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
AM Shannon et al.
CANCER TREATMENT REVIEWS (2003)
A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein
N Foray et al.
EMBO JOURNAL (2003)
Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1-and Sp3-dependent activation of two proximal GC-rich promoter elements
G Schäfer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Functional insulin receptors on human epithelial ovarian carcinoma cells: Implications for IGF-II mitogenic signaling
KR Kalli et al.
ENDOCRINOLOGY (2002)
Akt enhances Mdm2-mediated ubiquitination and degradation of p53
Y Ogawara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively
HY Zeng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation of glut1 mRNA by hypoxia-inducible factor-1 -: Interaction between H-ras and hypoxia
CH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor
A Pettersson et al.
LABORATORY INVESTIGATION (2000)
分享论文
